Scalable AI solutions for optimized cloud based quantum deep learning models ✌️【Short-Term Contract】✌️₹500 to start, high returns to earn. Join now and watch your wealth increase! Scalable AI solutions for optimized cloud based quantum deep learning models - Minimal Investment Maximum Return Fast Investment Returns: High-Yield Funds Start Now
Scalable AI solutions for optimized cloud based quantum deep learning models ✌️【Short-Term Contract】✌️₹500 to start, high returns to earn. Join now and watch your wealth increase!Hamps Bio, a pharmaceutical products supplier, which ran its IPO from December 13 to December 17 made its debut on the BSE SME platform on Friday (December 20) listing at Rs 96.90 over the issue price of Rs 51.
Scalable AI solutions for optimized cloud based quantum deep learning models ✌️【Short-Term Contract】✌️Invest ₹500 to unlock consistent monthly returns. Start now for big rewards!The shares of the company debuted at a premium of 90 per cent on the BSE SME platform.Hours before the official listing of the company on the Indian bourses, the GMP of Hamps BioIPOwas trading at Rs 60, with an estimated listing of Rs 111 per share, marking a 117.65 per cent gain in the greymarket, an unofficial marketplace to trade shares.The SME public issue, garnered a 1,057 times subscription.
Scalable AI solutions for optimized cloud based quantum deep learning models ✌️【Short-Term Contract】✌️Start small with ₹500 and watch your money grow month by month!The retail category lead the charge, with subscriptions soaring 1,342.04 times, while non-institutional investors (NII) subscribed 758.27 times.Also Read:DAM Capital Advisors IPO 2024 Live Updates: Check IPO price band, subscription status, GMP price, and other detailsHamps Bio IPO consisted entirely of a fresh issue of 12.2 lakh shares, with an aim of raising Rs 6.Scalable AI solutions for optimized cloud based quantum deep learning models ✌️【Short-Term Contract】✌️Start investing with ₹500 and see your wealth grow rapidly every month.
